This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Vidal, M. Articles by Cagan, R. L. Search for Related Content PubMed PubMed Citation Articles by Vidal, M. Articles by Cagan, R. L.

Differing Src Signaling Levels Have Distinct Outcomes in Drosophila

¹ Brookdale Department of Molecular, Cell, and Developmental Biology, Mount Sinai School of Medicine, New York, New York; ² Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, Missouri; and ³ Molecular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, California

Requests for reprints: Ross L. Cagan, Department of Molecular, Cell and Developmental Biology, Mount Sinai School of Medicine, 25-76 Annenberg Building, One Gustave L. Levy Place, Box 1020, New York, NY 10029. Phone: 212-241-1427; Fax: 212-860-9279; E-mail: Ross.Cagan{at}mssm.edu.

High levels of Src activity are found in a broad spectrum of cancers. The roles of Src and its negative regulator Csk have been extensively studied, although results have often proved contradictory or the relevance to whole organisms is unclear. In Drosophila, overexpression of either Src orthologue resulted in apoptotic cell death, but paradoxically, reducing dCsk activity led to over-proliferation and tissue overgrowth. Here, we show that in Drosophila epithelia in situ, the levels of Src signaling determine the cellular outcome of Src activation. Apoptotic cell death was triggered specifically at high Src signaling levels; lower levels directed antiapoptotic signals while promoting proliferation. Furthermore, our data indicate that expression of kinase-dead Src isoforms do not necessarily act as dominant-negative factors, but can instead increase Src pathway activity, most likely by titrating Csk activity away from endogenous Src. The importance of Src activity levels was emphasized when we examined oncogenic cooperation between Src and Ras: malignant overgrowth was observed specifically when high Src signaling levels were achieved. We propose a model in which low levels of Src signaling promote survival and proliferation during early stages of tumorigenesis, whereas strong Src signaling, coupled with antiapoptotic signals, directs invasive migration and metastasis during advanced tumor stages. [Cancer Res 2007;67(21):10278–85]